1. Home
  2. WVE vs REF Comparison

WVE vs REF Comparison

Compare WVE & REF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$5.06

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Reformation Inc. Common Stock

REF

Reformation Inc. Common Stock

N/A

Current Price

$15.04

Market Cap

886.1M

ML Signal

N/A

Company Overview

Basic Information
Metric
WVE
REF
Founded
2012
N/A
Country
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
886.1M
IPO Year
2015
2026

Fundamental Metrics

Financial Performance
Metric
WVE
REF
Price
$5.06
$15.04
Analyst Decision
Strong Buy
Analyst Count
16
0
Target Price
$29.81
N/A
AVG Volume (30 Days)
3.2M
443.5K
Earning Date
04-28-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,704,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$85.67
N/A
P/E Ratio
N/A
N/A
Revenue Growth
149.43
N/A
52 Week Low
$5.01
$12.83
52 Week High
$21.73
$17.26

Technical Indicators

Market Signals
Indicator
WVE
REF
Relative Strength Index (RSI) 39.27 45.47
Support Level $5.02 $12.83
Resistance Level $6.39 $16.74
Average True Range (ATR) 0.31 0.86
MACD -0.01 -0.07
Stochastic Oscillator 2.26 60.36

Price Performance

Historical Comparison
WVE
REF

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Inc is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About REF Reformation Inc. Common Stock

Reformation Inc sells apparel and accessories through its website, company-owned retail stores, wholesale channels, and other distribution channels in the United States and internationally. Its product portfolio includes dresses, bottoms, tops, sweaters, and accessories. The company focuses on womenswear and sources materials and products through its supply chain operations. The majority of the company's revenue was derived from the sale of its apparel and accessories, including clothing, shoes, and bags, through e-commerce and retail. Geographically, the maximum revenue is generated from the United States.

Share on Social Networks: